The new platform brings together advanced analysis, purpose-built AI, and curated biological data so researchers can move more quickly from complex genomic and multiomic data to actionable insight Included in the new platform, latest DRAGEN update expands access to Illumina’s award-winning secondary analysis across supported cloud and standard computing environment SAN DIEGO — Illumina, Inc. […]
The funding follows new research on a benchmark for chemistry AI, with Albert’s specialized AI outperforming frontier retrieval models with 45x better scientific accuracy. OAKLAND, Calif. — Albert, which has built the first chemistry-native AI operating system for R&D, today announced a $55 million Series B led by TCV with participation from new investors Delta-v […]
https://www.youtube.com/channel/UC-O3rHG8SOJUhw7xsN3l5TA OAKLAND, Calif. – Albert, which has built the first chemistry-native AI operating system for R&D, today announced a $55 million Series B led by TCV with participation from new investors Delta-v Capital, Socium Ventures, HighSage Ventures, Coral Capital, and Legion VC. They are joined by existing investors Coatue, J.P. Morgan Growth Equity Partners, Index […]
BOSTON — SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN) today announce a collaboration to advance new prostate cancer-specific genomic instability score (PrGIS) technology to support precision oncology approaches with AstraZeneca (LSE/STO/NYSE: AZN). PrGIS is a novel biomarker signature designed to assess chromosomal instability associated with homologous recombination deficiency (HRD) in prostate cancer patients. The […]
In a rare disease research dataset, SpliceAI2 identified 17% more disease-relevant variants compared to other splicing models Illumina’s genomic AI models now collectively enable researchers to identify 2x as many variants with predicted biological impact SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today introduced SpliceAI2, a new genomic AI model designed to address one of […]
Collaboration will apply Turin to explore mechanistic QSP model structures at scale and bring insights to development decisions where traditional modeling timelines have limited their use RESEARCH TRIANGLE PARK, N.C. — Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today […]
TUCSON, AZ — Clinisys, a global leader in laboratory informatics, today announced the expansion of its innovation portfolio with integrated document intelligence capabilities in Clinisys™ Laboratory Solution (CLS), helping laboratories capture, govern, search, and activate information across scientific and operational workflows while advancing Clinisys’s vision of connected laboratory intelligence. As laboratories continue to generate growing […]
The Scientific Intelligence Platform for AI-driven discovery is now available to every organization building on Databricks Boston, MA – Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced that Luma, its Scientific Intelligence Platform, has achieved Gold tier status in the Databricks Brickbuilder Partner Network and is now available on the […]
RESEARCH TRIANGLE PARK, N.C. — Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced the completion of its acquisition by affiliates of Altaris, LLC (“Altaris”), an investment firm focused exclusively on the healthcare industry. The transaction was originally announced […]
New IPA Investigator lets researchers ask biological questions in natural language and examine the scientific evidence behind the results New QIAGEN Discovery Platform extends AI into drug discovery workflows QIAGEN builds on more than 25 years of biomedical knowledge, with QDI tools used by around 150,000 users VENLO, Netherlands & GERMANTOWN, Md. — QIAGEN N.V. […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
